Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.
Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.
Expert Opin Drug Saf. 2020 May 19;:1-2
Authors: Monti M, Silimbani P, Ruscelli S, Frassineti GL
PMID: 32427001 [PubMed - as supplied by publisher]
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research
More News: Aortic Aneurysm | Avelox | Brain | Cipro | Ciprofloxacin | Disability | Drugs & Pharmacology | European Medicines Agency (EMA) | Food and Drug Administration (FDA) | Levaquin | Moxifloxacin | Neurology | Toxicology